Title : Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.

Pub. Date : 2008 Feb 2

PMID : 18083161






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Berberine nuclear factor kappa B subunit 1 Homo sapiens
2 This study focused on the suppressive effects of berberine on receptor activator of nuclear factor kappaB (NF-kappaB) ligand (RANKL)-induced osteoclastogenesis and survival. Berberine nuclear factor kappa B subunit 1 Homo sapiens
3 Berberine attenuated RANKL-induced activation of NF-kappaB through inhibiting phosphorylation at the activation loop of IkappaBalpha kinase beta, phosphorylation and degradation of IkappaBalpha, and NF-kappaB p65 nuclear translocation. Berberine nuclear factor kappa B subunit 1 Homo sapiens
4 Berberine attenuated RANKL-induced activation of NF-kappaB through inhibiting phosphorylation at the activation loop of IkappaBalpha kinase beta, phosphorylation and degradation of IkappaBalpha, and NF-kappaB p65 nuclear translocation. Berberine nuclear factor kappa B subunit 1 Homo sapiens
5 These findings indicate that berberine inhibits osteoclast formation and survival through suppression of NF-kappaB and Akt activation and that both pathways in the osteoclast lineage are highly sensitive to berberine treatment. Berberine nuclear factor kappa B subunit 1 Homo sapiens